Lisa Pearson, CRNA
Nurse Anesthetist, Certified Registered · Canon City, CONPI 1790749604
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Pacira Pharmaceuticals Incorporated accounts for 77.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $5,183 and has fallen 95.0% since, to $261 in 2025. Among nurse anesthetist, certified registered clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $72.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$6K
- Collegium Pharmaceutical, Inc.$432
- Scilex Pharmaceuticals Inc.$344
- AbbVie$244
- Merz North America, Inc.$198
- USWM, LLC$62
- plus $332 from 11 others
What the payments were for
- Consulting fees$3,64051%
- Travel & lodging$1,54722%
- Food & beverage$2,00028%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 14 | $5,574 |
| Collegium Pharmaceutical, Inc. | 29 | $432 |
| Scilex Pharmaceuticals Inc. | 25 | $344 |
| AbbVie | 7 | $244 |
| Merz North America, Inc. | 3 | $198 |
| USWM, LLC | 3 | $62 |
| Amgen | 3 | $55 |
| Lilly USA, LLC | 2 | $44 |
| Biodelivery Sciences International, Inc. | 3 | $39 |
| Vertex | 2 | $36 |
| Saluda Medical Americas, Inc. | 1 | $30 |
| Bioventus LLC | 2 | $30 |
| Avanos Medical | 1 | $26 |
| Medtronic | 1 | $23 |
| Averitas Pharma Inc. | 1 | $17 |
| Nevro Corp. | 1 | $17 |
| Boston Scientific | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$4,686
- IOVERA SYSTEM$522
- XEOMIN$141
- UBRELVY$125
How this compares
$7,187 in reported general payments places this provider in the 95th percentile of 452 nurse anesthetist, certified registered providers in Colorado.
See all nurse anesthetist, certified registered providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 72 | $60,460 |
| Xtampza ErOxycodone Myristate | 60 | $26,030 |
| Nucynta ErTapentadol Hcl | 19 | $18,127 |
| ZtlidoLidocaine | 11 | $11,108 |
| NucyntaTapentadol Hcl | 16 | $10,185 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 159 | $6,718 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 163 | $5,113 |
| Hysingla ErHydrocodone Bitartrate | 13 | $4,838 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 22 | $2,994 |
| Buprenorphine | 14 | $2,884 |
| Oxycodone Hcl | 129 | $2,333 |
| Morphine Sulfate ErMorphine Sulfate | 86 | $2,220 |
| Tramadol Hcl ErTramadol Hcl | 23 | $1,398 |
| Morphine Sulfate | 37 | $1,250 |
| Pregabalin | 58 | $1,235 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er, Nucynta | $432 | $114,802167 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $344 | $11,10811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 452 nurse anesthetist, certified registered providers in Colorado.
Other nurse anesthetist, certified registered in Canon City
- Theresa KeeferCanon City$835
- Angela GardnerThornton$27K
- Christopher PerezAurora$13K
- Sarina CranageEnglewood$8K
- Paul MeredithWray$4K
- Lauren HammLafayette$3K
- Christine CroomGreenwood Village$3K
- Crystal ThompsonLakewood$3K
- Kurt PorterWindsor$2K
- Carl BarlowCastle Rock$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.